Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transcriptional control and signal transduction, cell cycle

Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3

Abstract

Myeloproliferative neoplasms (MPN), which overproduce blood cells in the bone marrow, have recently been linked with a genetically determined decrease in expression of the MYB transcription factor. Here, we use a mouse MYB knockdown model with an MPN-like phenotype to show how lower levels of MYB lead to stem cell characteristics in myeloid progenitors. The altered progenitor properties feature elevated cytokine responsiveness, especially to interleukin-3, which results from increased receptor expression and increased MAPK activity leading to enhanced phosphorylation of a key regulator of protein synthesis, ribosomal protein S6. MYB acts on MAPK signaling by directly regulating transcription of the gene encoding the negative modulator SPRY2. This mechanistic insight points to pathways that might be targeted therapeutically in MPN.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

Accession codes

Accessions

Gene Expression Omnibus

References

  1. Campbell PJ, Green AR . The myeloproliferative disorders. N Engl J Med 2006; 355: 2452–2466.

    Article  CAS  PubMed  Google Scholar 

  2. Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med 2013; 369: 2379–2390.

    Article  CAS  PubMed  Google Scholar 

  3. Pardanani AD, Levine RL, Lasho T, Pikman Y, Mesa RA, Wadleigh M et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood 2006; 108: 3472–3476.

    Article  CAS  PubMed  Google Scholar 

  4. Tapper W, Jones AV, Kralovics R, Harutyunyan AS, Zoi K, Leung W et al. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms. Nat Commun 2015; 6: 6691.

    Article  CAS  PubMed  Google Scholar 

  5. Garcia P, Clarke M, Vegiopoulos A, Berlanga O, Camelo A, Lorvellec M et al. Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis. EMBO J 2009; 28: 1492–1504.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lieu YK, Reddy EP . Conditional c-myb knockout in adult hematopoietic stem cells leads to loss of self-renewal due to impaired proliferation and accelerated differentiation. Proc Natl Acad Sci USA 2009; 106: 21689–21694.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Clarke M, Dumon S, Ward C, Jager R, Freeman S, Dawood B et al. MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia. Leukemia 2013; 27: 661–670.

    Article  CAS  PubMed  Google Scholar 

  8. Krutzik PO, Nolan GP . Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 2003; 55: 61–70.

    Article  PubMed  Google Scholar 

  9. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G . Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009; 27: 543–549.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Dumon S, Walton DS, Volpe G, Wilson N, Dasse E, Del Pozzo W et al. Itga2b regulation at the onset of definitive hematopoiesis and commitment to differentiation. PLoS One 2012; 7: e43300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, Taunton J et al. RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 2007; 282: 14056–14064.

    Article  CAS  PubMed  Google Scholar 

  12. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J . Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J 2003; 22: 4478–4488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Pinto, do OP, Kolterud A, Carlsson L . Expression of the LIM-homeobox gene LH2 generates immortalized steel factor-dependent multipotent hematopoietic precursors. EMBO J 1998; 17: 5744–5756.

    Article  Google Scholar 

  14. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991; 65: 677–689.

    Article  CAS  PubMed  Google Scholar 

  15. Sandberg ML, Sutton SE, Pletcher MT, Wiltshire T, Tarantino LM, Hogenesch JB et al. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. Dev Cell 2005; 8: 153–166.

    Article  CAS  PubMed  Google Scholar 

  16. Guibal FC, Alberich-Jorda M, Hirai H, Ebralidze A, Levantini E, Di Ruscio A et al. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood 2009; 114: 5415–5425.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bruns I, Czibere A, Fischer JC, Roels F, Cadeddu RP, Buest S et al. The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence. Leukemia 2009; 23: 892–899.

    Article  CAS  PubMed  Google Scholar 

  18. Jin L, Lee EM, Ramshaw HS, Busfield SJ, Peoppl AG, Wilkinson L et al. Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells. Cell Stem Cell 2009; 5: 31–42.

    Article  CAS  PubMed  Google Scholar 

  19. Chen H, Guo R, Zhang Q, Guo H, Yang M, Wu Z et al. Erk signaling is indispensable for genomic stability and self-renewal of mouse embryonic stem cells. Proc Natl Acad Sci USA 2015; 112: E5936–E5943.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Geest CR, Coffer PJ . MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol 2009; 86: 237–250.

    Article  CAS  PubMed  Google Scholar 

  21. Malumbres M, Barbacid M . RAS oncogenes: the first 30 years. Nat Rev Cancer 2003; 3: 459–465.

    Article  CAS  PubMed  Google Scholar 

  22. Lyubynska N, Gorman MF, Lauchle JO, Hong WX, Akutagawa JK, Shannon K et al. A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice. Sci Transl Med 2011; 3: 76ra27.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Yusoff P, Lao DH, Ong SH, Wong ES, Lim J, Lo TL et al. Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of Raf. J Biol Chem 2002; 277: 3195–3201.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported entirely by Bloodwise.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Frampton.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Clarke, M., Volpe, G., Sheriff, L. et al. Transcriptional regulation of SPROUTY2 by MYB influences myeloid cell proliferation and stem cell properties by enhancing responsiveness to IL-3. Leukemia 31, 957–966 (2017). https://doi.org/10.1038/leu.2016.289

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2016.289

This article is cited by

Search

Quick links